-
UPDATE - New Study Reveals Potential Treatment for Neurological Lyme Disease
19 Apr 2024 16:45 GMT
… anti-inflammatory supplementary treatment for neurological Lyme disease … Lyme disease and other neurological diseases,” said Geetha Parthasarathy, … role in many developmental and metabolic disorders … FDA approved FGFR inhibitors for cancer, those drugs …
-
Speech Therapy Market to Surpass $17 Billion by 2031; Driven by Rising Prevalence of Speech and Neurological Disorders
18 Apr 2024 05:53 GMT
The speech therapy market size was valued at $9.9 billion in 2021, and is estimated to reach $17 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
WILMINGTON, DELAWARE , UNITED STATES, April 18, 2024 /EINPresswire.com/ -- A new …
-
Novel Parkinson’s Disease Drug Will Join AbbVie With Positive Phase 3 Data In Hand
18 Apr 2024 22:15 GMT
… drug’s developer, Cambridge, Massachusetts-based Cerevel Therapeutics, treatment … other neurological diseases. A Phase 2 trial evaluating the drug …
Cerevel focuses on developing drugs for neuroscience indications. … also developed ABBV-951 for treating motor …
-
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
18 Apr 2024 20:30 GMT
… a clinical-stage pharmaceutical company developing protein kinase inhibitor … the National Institute of Neurological Disease and Stroke (NINDS), … to bring transformative treatments for patients across … complete the 201 Trial evaluating risvodetinib in …
-
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
18 Apr 2024 20:00 GMT
… treatment for pain, mental health, and neurological disorders. Ketamine has been on the FDA … ’s drug … PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is focused on the development … to treat responsive …
-
Cannabis compound may offer treatment for brain disorders: study
18 Apr 2024 17:42 GMT
… offer a novel treatment solution for neurological disorders like Alzheimer’s … this chemical can be developed for use to protect … promise for CBN in treating conditions like a traumatic brain … to replicate and refine its drug-like properties,” Maher said. …
-
AI Identifies New Potential Treatments For Parkinson’s Disease
18 Apr 2024 17:08 GMT
… of potential new drugs to treat Parkinson's … and expensive process. Developing a drug from early laboratory testing … the Fixel Institute for Neurological Diseases at the University of … no curative treatments for the disease, only drugs to manage …
-
New Study Reveals Potential Treatment for Neurological Lyme Disease
18 Apr 2024 15:00 GMT
… anti-inflammatory supplementary treatment for neurological Lyme disease … Lyme disease and other neurological diseases,” said Geetha Parthasarathy, … role in many developmental and metabolic disorders … FDA approved FGFR inhibitors for cancer, those drugs …
-
Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and...
18 Apr 2024 14:19 GMT
… , structure-modifying drug for treatment of knee osteoarthritis … safe approach for treating knee osteoarthritis that … including osteoarthritis, cancer, neurological disorders, and diabetes. With … Biosplice’s drugs in clinical development include lorecivivint …
-
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
18 Apr 2024 14:52 GMT
… support late-phase drug developers from Phase 2 … GMP services to drug developers since the debut … ® mRNA capping technology. Pharmaceutical leaders, biotech disruptors, … treatments in oncology, infectious diseases, cardiology, and neurological disorders, …